Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Cat-PAD in Cat Allergic Paediatric Subjects
NCT01921257Phase 2Completed
- Sponsor
- NIOX Group
- Start
- Aug 2013
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
A Phase 2 trial of Cat-PAD in Rhinoconjunctivitis (RC), sponsored by NIOX Group. Started Aug 2013; status: completed.
02
Drugs
Cat-PAD
03
Conditions
Rhinoconjunctivitis (RC)
Beyond the preview
Go deeper on NCT01921257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01921257.